A latent Axin2+/Scx+ progenitor pool is the central organizer of tendon healing

Follicle rupture and luteinization during mammalian ovulation are informed by functionally and molecularly distinct regions of the ovarian follicle wall

Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer [Spatial Transciptomics]

Tumor Associated Macrophages And Microglia Drive Tumor Progression And Are Transcriptionally Shaped By Histone Mutations In Pediatric Diffuse Midline Glioma

ARF alters PAF1 complex integrity to selectively repress oncogenic transcription programs upon p53 loss

RNA-Seq in PBS- and mouse αSyn PFF-treated mouse primary cultured neurons

Intracellular zinc protects tumors from T cell-mediated cytotoxicity [MC38 RNAseq]

Determination of the tumor microenvironment remodeling by KRAS targeted therapy in pancreatic cancer

Nuclear Factor NFAT5 Governs Cellular Plasticity-Induced KRAS-Targeted Therapy Resistance in Pancreatic Cancer

Cell type-specific weighting-factors to solve solid organs-specific limitations of single cell RNA-sequencing

Drosha loss drives pineoblastoma by upregulating Ccnd2 [smallRNAseq of normal brain, Drosha tumor, and pineal gland

NG2+ and Tbx18+ pericyte subtypes exhibit distinct reprogramming potency following ischemic stroke

Effect of abrogated DNA-binding of thyroid hormone receptor alpha on the gene expression in CD25- CD4+ naive T cells and CD25+ CD4+ regulatory T cells

Mitochondrial fusion limits breast cancer metastasis

Gene expression changes associated with loss of Foxc1 in meningeal tissue of E14.5 mouse embryos

Viral TRAP RNAseq Data from Ipsilateral and Contralateral Corticospinal Neurons in Mouse

Kras loss of heterozygosity promotes MAPK dependent pancreatic ductal adenocarcinoma and induces therapeutic sensitivity

Tbx1 haploinsufficiency induces bone-to-cerebellar deformity in 22q11.2 deletion syndrome

Non-Canonical PRC1.1 is required for the activity of Menin-MLL1 Inhibitors in NUP98-Rearranged AML [SLAM-Seq]

Non-Canonical PRC1.1 is required for the activity of Menin-MLL1 Inhibitors in NUP98-Rearranged AML [RNA-seq]